National Health Investors (NYSE:NHI) has been given a $79.00 price objective by stock analysts at Stephens in a note issued to investors on Friday. The firm presently has a “buy” rating on the real estate investment trust’s stock. Stephens’ price objective would suggest a potential upside of 13.28% from the stock’s current price.
A number of other equities analysts have also recently weighed in on the company. KeyCorp reissued an “underweight” rating on shares of National Health Investors in a report on Tuesday, December 19th. Zacks Investment Research cut National Health Investors from a “buy” rating to a “hold” rating in a report on Friday, November 17th. ValuEngine raised National Health Investors from a “hold” rating to a “buy” rating in a report on Friday, November 10th. Capital One Financial assumed coverage on National Health Investors in a report on Monday, October 23rd. They set an “equal weight” rating on the stock. Finally, BMO Capital Markets reissued a “hold” rating and set a $80.00 price objective on shares of National Health Investors in a report on Wednesday, October 18th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. National Health Investors has an average rating of “Hold” and an average target price of $80.00.
Shares of National Health Investors (NYSE NHI) traded down $1.37 during midday trading on Friday, hitting $69.74. The company had a trading volume of 303,010 shares, compared to its average volume of 215,131. The stock has a market cap of $2,900.00, a PE ratio of 17.44, a price-to-earnings-growth ratio of 3.36 and a beta of 0.59. The company has a current ratio of 12.72, a quick ratio of 12.72 and a debt-to-equity ratio of 0.84. National Health Investors has a 52 week low of $68.96 and a 52 week high of $81.60.
WARNING: “Stephens Analysts Give National Health Investors (NHI) a $79.00 Price Target” was published by American Banking and Market News and is owned by of American Banking and Market News. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/13/stephens-analysts-give-national-health-investors-nhi-a-79-00-price-target.html.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.